Today: 20 May 2026
NexGen Energy stock jumps as uranium names rally on Canada project milestone
2 January 2026
1 min read

NexGen Energy stock jumps as uranium names rally on Canada project milestone

New York, January 2, 2026, 1:02 PM ET — Regular session

  • NexGen Energy shares rose nearly 10% in midday trade, outperforming the broader market.
  • Uranium-linked stocks moved higher after peer Denison outlined a near-term construction pathway for its Phoenix project.
  • Investors’ next calendar marker for NexGen is a Canadian nuclear regulator hearing in February.

NexGen Energy Ltd shares climbed 9.8% to $10.10 in midday New York trading on Friday, after touching $10.20 earlier in the session.

The move put the uranium developer among the stronger gainers in the space on the first trading day of 2026, as investors focused on regulatory and construction progress across Canada’s pipeline of new uranium supply.

That matters because developers’ valuations tend to swing on confidence in permitting timelines and build costs, not current production, and Friday’s sector tape leaned into “shovel-ready” signals rather than long-dated exploration upside.

Denison Mines said it was ready to make a final investment decision and commence construction of its Phoenix in-situ recovery (ISR) uranium mine — a technique that recovers uranium by circulating solution through the orebody instead of digging out rock — while updating its post-decision initial capital cost estimate to $600 million, 20% higher than its 2023 feasibility study when adjusted for inflation. “Denison stands ready to make a final investment decision and commence construction of the Phoenix ISR mine,” President and CEO David Cates said in a statement. PR Newswire

Reuters reported Denison’s shares jumped after the miner flagged readiness to launch its Phoenix ISR project.

Uranium futures were quoted at about $81.65 per pound, according to Investing.com, as traders tracked the sector’s sensitivity to price expectations and utility contracting appetite.

NexGen, which is advancing the proposed underground Rook I uranium mine and mill in Saskatchewan’s Athabasca Basin, is still working through Canada’s federal licensing and environmental assessment process.

For NexGen specifically, the Canadian Nuclear Safety Commission has scheduled a two-part public hearing on its licence application, with Part 2 set for February 9–13, 2026, following a virtual session held on November 19, 2025.

Beyond the regulatory calendar, investors continue to weigh longer-run demand expectations against the industry’s ability to bring supply online, after the World Nuclear Association forecast uranium demand in reactors would rise 28% by 2030 and more than double by 2040.

Traders also tend to watch whether project cost inflation — highlighted again by Denison’s revised Phoenix capex — forces developers to raise more capital or stretch schedules, which can dilute shareholders.

Stock Market Today

  • Applied Digital, Viasat, CECO Environmental, and HNI Shares Plunge Amid Rising Yields and Oil Prices
    May 20, 2026, 5:35 PM EDT. Applied Digital (APLD), Viasat, CECO Environmental, and HNI stocks suffered sharp declines in afternoon trading due to surging 10-year Treasury yields hitting 4.56%, a one-year high, and rising WTI crude oil prices near $104 per barrel amid geopolitical tensions. The market also reacted negatively to the lack of concrete agreements from the recent U.S.-China summit. Applied Digital remains notable, trading near its 52-week high at $42.53 after signing long-term AI data center deals expected to generate $7 billion in revenue over 15 years, reflecting strong positioning in the growing AI infrastructure sector. The broader sell-off weighed on major indexes, including the S&P 500 and Nasdaq, pulling them back from record highs.

Latest articles

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
e.l.f. Beauty Earnings Beat Comes With a Catch for Wall Street

e.l.f. Beauty Earnings Beat Comes With a Catch for Wall Street

20 May 2026
e.l.f. Beauty forecast fiscal 2027 sales and adjusted profit below Wall Street estimates, citing $15–$20 million in potential oil-related costs from the Iran war. Fourth-quarter net sales rose 35% to $449.3 million, beating expectations, but the company posted a $49.4 million net loss due to a $57.6 million charge tied to the Rhode acquisition. Shares rose after hours despite closing down 4.3% earlier.
Boeing (BA) stock jumps today as $2.7 billion Apache support deal kicks off 2026 trading
Previous Story

Boeing (BA) stock jumps today as $2.7 billion Apache support deal kicks off 2026 trading

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal
Next Story

Hubble spots odd triple jets on interstellar comet 3I/ATLAS as radio search finds no alien signal

Go toTop